Cargando…

5-Hydroxymethylcytosine Loss in Conjunctival Melanoma

Aims: Conjunctival and cutaneous melanoma partially share similar clinical and molecular backgrounds. As 5-hydroxymethylcytosine (5-hmC) loss has been demonstrated in cutaneous melanoma, we decided to assess if similar changes were occurring in conjunctival melanoma. Methods: 5-methylcytosine (5-mC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stahl, Alexandre, Riggi, Nicolo, Nardou, Katya, Nicolas, Michael, Kaya, Gurkan, Moulin, Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293194/ https://www.ncbi.nlm.nih.gov/pubmed/34198758 http://dx.doi.org/10.3390/dermatopathology8020023

Ejemplares similares

β-Catenin Expression and Activation in Conjunctival Melanoma
por: Larivé, Emerentienne, et al.
Publicado: (2019)

Identification of New Vulnerabilities in Conjunctival Melanoma Using Image-Based High Content Drug Screening
por: Nardou, Katya, et al.
Publicado: (2022)

Genomic and transcriptomic landscape of conjunctival melanoma
por: Cisarova, Katarina, et al.
Publicado: (2020)

ATRX Loss in the Development and Prognosis of Conjunctival Melanoma
por: van Ipenburg, Jolique A., et al.
Publicado: (2023)

UV light signature in conjunctival melanoma; not only skin should be protected from solar radiation
por: Rivolta, Carlo, et al.
Publicado: (2016)

Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma
por: Lee, Jonathan J., et al.
Publicado: (2015)

Conjunctival melanoma
por: de Abreu, Marilda Aparecida Milanez Morgado, et al.
Publicado: (2018)

Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors
por: Larson, Allison R., et al.
Publicado: (2014)

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
por: Sjöström, Martin, et al.
Publicado: (2022)

The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing
por: Huang, Yun, et al.
Publicado: (2010)

Loss of 5-Hydroxymethylcytosine as an Epigenetic Signature That Correlates With Poor Outcomes in Patients With Medulloblastoma
por: Zhao, Fu, et al.
Publicado: (2021)

5-Hydroxymethylcytosine Expression in Metastatic Melanoma versus Nodal Nevus in Sentine Lymph Node Biopsies
por: Lee, Jonathan J., et al.
Publicado: (2014)

Medium throughput bisulfite sequencing for accurate detection of 5-methylcytosine and 5-hydroxymethylcytosine
por: Chen, Gary G., et al.
Publicado: (2017)

Alterations of 5-Hydroxymethylcytosine in Human Cancers
por: Mariani, Christopher J., et al.
Publicado: (2013)

Formation and Abundance of 5-Hydroxymethylcytosine in RNA
por: Huber, Sabrina M, et al.
Publicado: (2015)

Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma
por: Shi, Xuejiao, et al.
Publicado: (2016)

Synchronous conjunctival melanoma and lentigo maligna melanoma
por: Volpini, Beatrice Mussio Fornazier, et al.
Publicado: (2017)

Orbital exenteration and conjunctival melanoma: a 14-year study at the Jules Gonin Eye Hospital
por: Martel, A., et al.
Publicado: (2020)

Distribution of 5-Hydroxymethylcytosine in Different Human Tissues
por: Li, Weiwei, et al.
Publicado: (2011)

Management Issues in Conjunctival Tumours: Conjunctival Melanoma and Primary Acquired Melanosis
por: Cohen, Victoria M. L., et al.
Publicado: (2019)

5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas
por: Zhang, Feng, et al.
Publicado: (2016)

Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome
por: Kenawy, Nihal, et al.
Publicado: (2019)

Genomic mapping of 5-hydroxymethylcytosine in the human brain
por: Jin, Seung-Gi, et al.
Publicado: (2011)

Tet-Mediated Formation of 5-Hydroxymethylcytosine in RNA
por: Fu, Lijuan, et al.
Publicado: (2014)

The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases
por: Al-Mahdawi, Sahar, et al.
Publicado: (2014)

Physiological and pathological implications of 5-hydroxymethylcytosine in diseases
por: Liang, Jing, et al.
Publicado: (2016)

NF1 mutations in conjunctival melanoma
por: Scholz, S. L., et al.
Publicado: (2018)

Deciphering TAL effectors for 5-methylcytosine and 5-hydroxymethylcytosine recognition
por: Zhang, Yuan, et al.
Publicado: (2017)

Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression
por: Marçais, Ambroise, et al.
Publicado: (2016)

5-Methylcytosine and 5-Hydroxymethylcytosine Spatiotemporal Profiles in the Mouse Zygote
por: Salvaing, Juliette, et al.
Publicado: (2012)

Tissue-specific 5-hydroxymethylcytosine landscape of the human genome
por: He, Bo, et al.
Publicado: (2021)

5-hydroxymethylcytosine and gene activity in mouse intestinal differentiation
por: Uribe-Lewis, Santiago, et al.
Publicado: (2020)

Systemic Treatment of Metastatic Conjunctival Melanoma
por: Pinto Torres, Simão, et al.
Publicado: (2017)

Conjunctival melanoma in an African American man
por: Oh, Daniel Jungmyung, et al.
Publicado: (2020)

Amelanotic conjunctival melanoma in a child
por: Vishnevskia-Dai, Vicktoria, et al.
Publicado: (2022)

Trends in Incidence of Conjunctival Melanoma in the US
por: Weppelmann, Thomas A., et al.
Publicado: (2022)

Conjunctival Melanoma: A Case Presentation
por: Montazer, Fatemeh, et al.
Publicado: (2023)

Recognition of 5-Hydroxymethylcytosine by the Uhrf1 SRA Domain
por: Frauer, Carina, et al.
Publicado: (2011)

5'-Hydroxymethylcytosine Precedes Loss of CpG Methylation in Enhancers and Genes Undergoing Activation in Cardiomyocyte Maturation
por: Kranzhöfer, David K., et al.
Publicado: (2016)

5-Methylcytosine and 5-Hydroxymethylcytosine Signatures Underlying Pediatric Cancers
por: Jhanwar, Shalu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ocmoc3e2v138pegm3okbbquap0